FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992657918> ?p ?o ?g. }

• W1992657918 endingPage "47" @default.
• W1992657918 startingPage "43" @default.
• W1992657918 abstract "Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by abdominal pain, discomfort, and altered bowel habits, which have a significant impact on quality of life for approximately 10-20% of the population. IBS can be divided into three main types IBS-D (diarrhea predominant), IBS-C (constipation predominant), and mixed or alternating IBS. 5-HT(3) receptor antagonism has proved to be an efficacious treatment option for IBS-D. For example, alosetron displays efficacy in the treatment of multiple symptoms, including abdominal pain, discomfort, urgency, stool frequency and consistency. However, significant constipation occurred in approximately 25% of patients, leading to withdrawal of up to 10% of patients in clinical trials. Targeting compounds with partial agonist activity at the 5-HT(3) receptor represents a mechanistic departure from the classic 5-HT(3) receptor antagonist approach and should result in agents that are applicable to a broader array of IBS patient populations. Attenuation of the activity of the ion channel without completely abolishing its function may control or normalize bowel function without leading to a total block associated with severe constipation. We have identified a new class of selective, orally active 5-HT(3) receptor ligands with high 5-HT(3) receptor affinity and low partial agonist activity currently in preclinical development that should offer a significant advantage over existing therapies." @default.
• W1992657918 created "2016-06-24" @default.
• W1992657918 creator A5021048548 @default.
• W1992657918 creator A5047963260 @default.
• W1992657918 creator A5061329458 @default.
• W1992657918 creator A5080655193 @default.
• W1992657918 date "2012-12-24" @default.
• W1992657918 modified "2023-09-26" @default.
• W1992657918 title "Partial Agonism of 5-HT₃ Receptors: A Novel Approach to the Symptomatic Treatment of IBS-D" @default.
• W1992657918 cites W1819750950 @default.
• W1992657918 cites W1894142717 @default.
• W1992657918 cites W1971179661 @default.
• W1992657918 cites W1972403965 @default.
• W1992657918 cites W1980399821 @default.
• W1992657918 cites W1983350548 @default.
• W1992657918 cites W1987268954 @default.
• W1992657918 cites W1998159103 @default.
• W1992657918 cites W2005395166 @default.
• W1992657918 cites W2006346166 @default.
• W1992657918 cites W2010163969 @default.
• W1992657918 cites W2011202557 @default.
• W1992657918 cites W2016766312 @default.
• W1992657918 cites W2035719855 @default.
• W1992657918 cites W2044801831 @default.
• W1992657918 cites W2054181324 @default.
• W1992657918 cites W2077354720 @default.
• W1992657918 cites W2078830320 @default.
• W1992657918 cites W2083665563 @default.
• W1992657918 cites W2086067329 @default.
• W1992657918 cites W2092801157 @default.
• W1992657918 cites W2097566770 @default.
• W1992657918 cites W2101520329 @default.
• W1992657918 cites W2121087428 @default.
• W1992657918 cites W2128077096 @default.
• W1992657918 cites W2136418207 @default.
• W1992657918 cites W2160303198 @default.
• W1992657918 doi "https://doi.org/10.1021/cn300166c" @default.
• W1992657918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3548414" @default.
• W1992657918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23342199" @default.
• W1992657918 hasPublicationYear "2012" @default.
• W1992657918 type Work @default.
• W1992657918 sameAs 1992657918 @default.
• W1992657918 citedByCount "20" @default.
• W1992657918 countsByYear W19926579182013 @default.
• W1992657918 countsByYear W19926579182014 @default.
• W1992657918 countsByYear W19926579182015 @default.
• W1992657918 countsByYear W19926579182017 @default.
• W1992657918 countsByYear W19926579182018 @default.
• W1992657918 countsByYear W19926579182019 @default.
• W1992657918 countsByYear W19926579182020 @default.
• W1992657918 countsByYear W19926579182023 @default.
• W1992657918 crossrefType "journal-article" @default.
• W1992657918 hasAuthorship W1992657918A5021048548 @default.
• W1992657918 hasAuthorship W1992657918A5047963260 @default.
• W1992657918 hasAuthorship W1992657918A5061329458 @default.
• W1992657918 hasAuthorship W1992657918A5080655193 @default.
• W1992657918 hasBestOaLocation W19926579182 @default.
• W1992657918 hasConcept C126322002 @default.
• W1992657918 hasConcept C170493617 @default.
• W1992657918 hasConcept C2776885963 @default.
• W1992657918 hasConcept C2778122271 @default.
• W1992657918 hasConcept C2778271842 @default.
• W1992657918 hasConcept C2778938600 @default.
• W1992657918 hasConcept C2780955771 @default.
• W1992657918 hasConcept C2781112942 @default.
• W1992657918 hasConcept C58732023 @default.
• W1992657918 hasConcept C71924100 @default.
• W1992657918 hasConcept C90924648 @default.
• W1992657918 hasConcept C98274493 @default.
• W1992657918 hasConceptScore W1992657918C126322002 @default.
• W1992657918 hasConceptScore W1992657918C170493617 @default.
• W1992657918 hasConceptScore W1992657918C2776885963 @default.
• W1992657918 hasConceptScore W1992657918C2778122271 @default.
• W1992657918 hasConceptScore W1992657918C2778271842 @default.
• W1992657918 hasConceptScore W1992657918C2778938600 @default.
• W1992657918 hasConceptScore W1992657918C2780955771 @default.
• W1992657918 hasConceptScore W1992657918C2781112942 @default.
• W1992657918 hasConceptScore W1992657918C58732023 @default.
• W1992657918 hasConceptScore W1992657918C71924100 @default.
• W1992657918 hasConceptScore W1992657918C90924648 @default.
• W1992657918 hasConceptScore W1992657918C98274493 @default.
• W1992657918 hasIssue "1" @default.
• W1992657918 hasLocation W19926579181 @default.
• W1992657918 hasLocation W19926579182 @default.
• W1992657918 hasLocation W19926579183 @default.
• W1992657918 hasLocation W19926579184 @default.
• W1992657918 hasOpenAccess W1992657918 @default.
• W1992657918 hasPrimaryLocation W19926579181 @default.
• W1992657918 hasRelatedWork W130502936 @default.
• W1992657918 hasRelatedWork W1780338288 @default.
• W1992657918 hasRelatedWork W1970700678 @default.
• W1992657918 hasRelatedWork W2006323963 @default.
• W1992657918 hasRelatedWork W2033874747 @default.
• W1992657918 hasRelatedWork W2072649600 @default.
• W1992657918 hasRelatedWork W2093095026 @default.
• W1992657918 hasRelatedWork W2118184782 @default.
• W1992657918 hasRelatedWork W2504779997 @default.
• W1992657918 hasRelatedWork W4386221107 @default.

• next